Treatment of Lyme Disease in Borrelial Lymphocytoma
This protocol covers Lyme disease in patients who present with borrelial lymphocytoma, outlining the recommended treatment approach for this specific clinical situation.
Clinical Scenario
The patient has Lyme disease with borrelial lymphocytoma. This presentation defines the clinical context and informs the recommended course of action.
Treatment Approach
Oral antibiotic therapy is the recommended approach for Lyme disease in this setting. The full protocol — including antibiotic selection and all treatment details — is available via the structured regimen below.
References
- In patients with borrelial lymphocytoma, we suggest oral antibiotic therapy for 14 days (weak recommendation, low-quality evidence).